lol Zecs I love your posts they disregard anything the company is doing or developed. The saltiness is wonderful with you. Go do some research before posting a generic response you can post on any asx stock on the asx.
Right now the company has fully developed proof of concept through 6 years of data and safety. They now are in human studies and with the development of drugs in the industry they have already proven for NYR the mechanism of action what the company needs to do right now is clear safety and bioavailability in the body the rest is a formality and with every milestone comes a rerate because the drug becomes further de risked. It’s why some biotechs are worth 500 million on phase 2 and 1 billion dollars plus on phase 3. It’s called investing
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22143 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 10.17am 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable